McCarthy Tétrault’s patent litigators honoured once again by Managing IP as best in Canada
Toronto, March 26, 2014 – McCarthy Tétrault is delighted to announce that at a gala in Washington, DC last night, Euromoney’s Managing IP honoured the firm with the national 2014 Patent Contentious award for Canada. This is McCarthy Tétrault’s second consecutive year to receive this prestigious recognition of its outstanding work for clients in their patent disputes in 2013.
In particular, the firm had significant successes in pharmaceutical and life sciences patent disputes. Among the team’s achievements were its
- assistance to Merck in Merck & Co. Inc. and Merck Canada Inc. v. Apotex Inc. et al., a case in which Merck recovered more than C$180 million in damages and interest for Apotex’s infringement of Merck’s Canadian Lovastatin patent – the largest patent damages award in Canadian history
- representation of AbbVie in its patent infringement case against Janssen related to AbbVie’s Canadian patent on anti-IL-12 antibodies. This was Canada’s first antibody engineering trial, and the action was the first in Canada dealing with the scope of protection for the new class of drugs known as "biologics". The Federal Court found AbbVie’s patent valid and infringed.
In addition to the patent litigators receiving this award, lead partners Andrew Reddon and Steven Mason were recently named by Euromoney Legal Media Group’s Benchmark Canada as Canada’s Intellectual Property Litigators of the Year – Patents for their work on these cases and others in 2013.
McCarthy Tétrault’s IP Litigation Group has deep knowledge of the technology, internet, communications, pharmaceutical and life sciences sectors. The team is frequently lauded for its performance in the defence of its clients’ patents, trademarks, trade secrets, copyright, industrial designs and other intellectual property assets in these industries. The firm’s IP expertise was recently recognized in Chambers Global 2014 as "acclaimed for its strategic and integrated approach across all aspects of intellectual property management" and "recognized as a dominant force in the Canadian IP market."
McCarthy Tétrault’s integrated litigation practice comprises more than 200 litigators across Canada. The firm’s litigators are experienced trial and appellate lawyers at all levels who have advised on cases across the spectrum – from complex litigation to insurance litigation and class actions. Sixty-three of the firm’s lawyers have been appointed judges of the superior courts, the courts of appeal and the Supreme Court of Canada.
Managing IP is a prominent source of news and analysis on intellectual property developments in 80 international jurisdictions, including the United States, Canada, Asia, Europe, the Middle East, Africa, Latin America and the Caribbean. Its events and awards programs recognize noteworthy firms and individuals’ achievements based on annual surveys of in-house and law firm practitioners globally. More information about the 2014 awards is found on Managing IP’s website.
About McCarthy Tétrault
McCarthy Tétrault provides a broad range of legal services, advising on large and complex assignments for Canadian and international interests. The firm has substantial presence in Canada’s major commercial centres and in London, UK.
Built on an integrated approach to the practice of law and delivery of innovative client services, the firm brings its legal talent, industry insight and practice experience to help clients achieve the results that are important to them.